Does Parathyroid Hormone Affect Erythropoietin Therapy in Dialysis Patients? | Zendy

Nabieh AlHilali | Zendy; Hani M. Alhumoud | Zendy; V.T. Ninan | Zendy; Mangalathillam R.N. Nampoory | Zendy; Mini A. Puliyclil | Zendy; K.V. Johny | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Parathyroid Hormone Affect Erythropoietin Therapy in Dialysis Patients?

Author(s) -

Nabieh AlHilali,

Hani M. Alhumoud,

V.T. Ninan,

Mangalathillam R.N. Nampoory,

Mini A. Puliyclil,

K.V. Johny

Publication year - 2006

Publication title -

medical principles and practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.426

H-Index - 45

eISSN - 1423-0151

pISSN - 1011-7571

DOI - 10.1159/000096143

Subject(s) - medicine , erythropoietin , parathyroid hormone , anemia , continuous ambulatory peritoneal dialysis , hyperparathyroidism , hemodialysis , dialysis , hematocrit , peritoneal dialysis , secondary hyperparathyroidism , endocrinology , gastroenterology , creatinine , urology , blood urea nitrogen , calcium

The objective of this study was to assess the response to recombinant human erythropoietin (rHuEPO) during treatment of anemia in dialysis patients with hyperparathyroidism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research